| PHARMABIZ WISHES ALL ITS READERS & ADVERTISERS A HAPPY & PROSPEROUS DIWALI. THE WEBSITE WILL NOT BE UPDATED ON OCTOBER 23 AND 24 ON ACCOUNT OF DIWALI
       
  Editorial
 PATENTED DRUGS & DPCO   
 Wednesday, October 22, 2014 
 Regulating prices of patented drugs marketed in the country is an issue dragging on with no decision forthcoming for the last several years. Although the Indian Patent Act was amended in 2005, the government has been attempting to bring some control on highly expensive patented drugs for more than six years. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]BioProcess Technology buys CTD Quality Consulting; forms advanceONE division
17:00  [IST]US FDA approves Auxilium Pharma's Xiaflex for concurrent treatment of up to 2 affected joints in same hand in DC patients
16:10  [IST]Biocon to spur global growth from Emerging Markets as MENA region throws up credit risk challenges
16:00  [IST]USFDA accepts filing of NDA for empagliflozin/metformin FDC
15:10  [IST]GVK BIO completes Drug Repurposing efforts to identify novel indications
15:00  [IST]Roche to invest 3 billion Swiss francs for new R&D centre in Basel
more news >>
TOP NEWS
08:00  [IST]Ayush dept issues draft notification on prefix-suffix amidst industry opposition
08:00  [IST]Maha FDA refers over 200 cases of absence of pharmacists to MSPC for action
08:00  [IST]Cura eyes buyouts & set to accelerate growth with eZono 4000 needle guidance system
08:00  [IST]Pharmacists demand strengthening of regulatory mechanism to check irrational use of antibiotics
08:00  [IST]TS govt to accept all demands of JUDAs except ‘compulsory rural service’
08:00  [IST]Centre to finalise modalities for nationwide study of spurious, NSQ drugs at DCC meet on Oct 27
more news >>
YESTERDAY'S NEWS
18:00  [IST]Study reveals likelihood & onset of MS diagnosis among patients with inflammatory eye disease
17:10  [IST]Over 600 Mumbaites ‘Walk for Life’ against breast cancer
17:00  [IST]US FDA committee recommends approval of Novartis' secukinumab to treat moderate-to-severe plaque psoriasis
16:00  [IST]Advocate Health Care, Abbott to conduct study on patients to quantify effectiveness of nutrition care in hospital settings
15:50  [IST]Experts press for early introduction of Injectable Polio Vaccine (IPV) in India
15:30  [IST]Indoco Remedies net jumps by 40% to Rs.22.41 cr in Q2
more news >>
INTERVIEW  
Gujarat FDCA: Playing crucial role in industry growth
Dr_H-G-Koshia.jpgDr H G Koshia, Gujarat FDCA commissioner
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |